Prognostic significance of tumor angiogenesis in endometrial cancer

Obstetrics and Gynecology

Volumn 93, Issue 3, 1999, Pages 367-371

  Obermair, Andreas ^a   Tempfer, Clemens ^a   Wasicky, Richard ^a   Kaider, Alexandra ^a   Hefler, Lukas ^a   Kainz, Christian ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

EID: 0033104281     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00417-7     Document Type: Article

References (24)

1. Folkman J. Tumor angiogenesis Therapeutic implications . N Engl J Med. 285:1971;1182-1186.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
3. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol. 147:1995;9-19.
4. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., Luna N., Morgan E., Yang J.J., et al. Angiogenesis factor in endometrial carcinoma A new prognostic indicator? Am J Obstet Gynecol. 174:1996;1879-1884.
5. Morgan K.G., Wilkinson N., Buckley C.H. Angiogenesis in endometrial carcinoma. Int J Gynecol Cancer. 6:1996;385-388.
6. Malviya V.K., Deppe G., Malone J.M. Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol. 34:1989;299-304.
7. Morrow C.P., Bundy B.N., Kurmann R.J. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium A Gynecologic Oncology Group study . Gynecol Oncol. 40:1991;55-65.
8. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delai D., et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 75:1990;2417-2426.
9. Kuzu I., Bicknell R., Harris A.L., Jones M., Gatter K.C., Mason D.Y. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol. 45:1992;143-148.
10. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 36:1995;169-180.
11. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Statist Assoc. 47:1952;583-621.
12. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc. 53:1985;457-481.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
14. Cox D.R. Regression models and life tables. J Roy Stat Soc [B]. 34:1972;187-220.
15. Morgan K.G., Wilkinson N., Buckley C.H. Angiogenesis in normal, hyperplastic and neoplastic endometrium. J Pathol. 179:1996;317-320.
16. Abulafia O., Triest W.E., Sherer D.M., Hansen C.C., Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol. 86:1995;479-485.
17. Willemse F., Nap M., Bruijn H.W.A., Hollema H. Quantification of vascular density and of lumen and vessel morphology in endometrial carcinoma. Analyt Quant Cytol Histol. 19:1997;1-7.
18. Kaku T., Kamura T., Kinukawa N., Kobayashi H., Sakai K., Tsuruchi N., et al. Angiogenesis in endometrial cancer. Cancer. 80:1997;741-747.
19. Salvesen H.B., Iversen O.E., Akslen L.A. Independent prognostic importance of microvessel density in endometrial carcinoma. Br J Cancer. 77:1998;1140-1144.
20. Wagatsuma S., Konno R., Sato S., Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-met expression in endometrial carcinoma. Cancer. 82:1998;520-530.
21. Hacker N.F. Uterine cancer. Hacker N.F., Berek J.S., Practical gynecologic oncology. 2nd ed. 1994;285-326 Williams and Wilkins, Baltimore, MD.
22. Barakat R.R., Park R.C., Grigsby P.W., Muss H.D., Norris H.J. Corpus: Epithelial tumors. Hoskins W.J., Perez C.A., Young R.C., Principles and practice of gynecologic oncology. 2nd ed. 1997;859-896 Lippincott-Raven, Philadelphia, PA.
23. Lindner D.J., Borden E.C. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis. Int J Cancer. 71:1997;456-461.
24. Yamamoto T., Terada N., Nishizawa Y., Petrow V. Angiostatic activities of medroxyprogesteron acetate and its analogues. Int J Cancer. 56:1994;393-399.